2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Changes in botulinum toxin dosing in cervical dystonia over 7 years

S. Rafee, M. Hutchinson (Dublin, Ireland)
Changes in gait and mobility measures collected in daily living conditions, in different stages of Parkinson’s disease

N. Geffen, K. Cohavi, N. Giladi, A. Thaler, R. Alcalay, J. Edgerton, J. Shirvan, J. Cedarbaum, J. Hausdorff, A. Mirelman (Tel Aviv, Israel)
Changes in the level of glial neurotrophic factor in Parkinson’s disease depending on the form

B. Muminov, R. Matmurodov, E. Abduqodirov (Tashkent, Uzbekistan)
Characterising Natural Killer cells in early Parkinson’s disease

J. Holbrook, B. Patel, M. Camacho, C. Williams-Gray (Cambridge, United Kingdom)
Characteristics and Techniques to Improve Micrographia in Parkinson’s Disease

S. Shahid (Southampton, USA)
Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Anterocollis Subtype of Cervical Dystonia

K. Dashtipour, J. Jankovic, D. Charles, S. Mehta, M. Schwartz, M. Sadeghi (Loma Linda, USA)
Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Retrocollis Subtype of Cervical Dystonia

K. Dashtipour, J. Jankovic, D. Charles, S. Mehta, M. Schwartz, M. Sadeghi (Loma Linda, USA)
Characteristics and validity of technologies analyzing voice features to assess symptoms – a review

J. Dean, V. Iankova Md, S. Schneider (Aurora, USA)
Characteristics of Fatigue and Correlation with the Symptoms of Parkinson’s Disease

XJ. Huang, Y. Qu, JT. Li, YP. Chen, JY. Li, QX. Qin, DL. Wang, JW. Zhao, ZJ. Mao, YJ. Xiong, Z. Min, Z. Xue (Wuhan, China)
Characterization of essential tremor patients in a central hospital-based sample.

A. Costa, C. Borges, C. Azoia, R. Jesus, R. Raimundo, AG. Velon (Vila Real, Portugal)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z